Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4067307

C1CNCCN1.CCN.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Trifluoroacetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.36
FUCA1 P04066 1/20 0.35
HRH4 Q9H3N8 4/20 0.34
HRH3 Q9Y5N1 3/20 0.34
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
THRB P10828 1/20 0.33
KMT2A Q03164 1/20 0.33
DPP8 Q6V1X1 3/20 0.33
DPP7 Q9UHL4 2/20 0.33
SLC1A2 P43004 2/20 0.33
DPP4 P27487 1/20 0.33
ODC1 P11926 2/20 0.32
CES2 O00748 1/20 0.32
KDM1A O60341 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4391008 0.85 TSHR (0.38) PKMFUCA1HRH4HRH3ALDH1A1
Trifluoroacetic Acid SCHEMBL6224514 0.85 FAAH (0.39) HRH4HRH3MEN1ALDH1A1CYP1A2
Trifluoroacetic Acid SCHEMBL359979 0.85 FAAH (0.39) HRH4HRH3MEN1ALDH1A1CYP1A2
Trifluoroacetic Acid SCHEMBL3471327 0.85 TSHR (0.38) PKMFUCA1HRH4HRH3ALDH1A1
Trifluoroacetic Acid SCHEMBL16115531 0.78 SMN1; SMN2 (0.47) PKMHRH4HRH3ALDH1A1KDM1A
Trifluoroacetic Acid SCHEMBL3983920 0.78 SMN1; SMN2 (0.47) PKMHRH4HRH3ALDH1A1KDM1A
Trifluoroacetic Acid SCHEMBL6826527 0.75 ALDH1A1 (0.42) PKMHRH4HRH3ALDH1A1KDM1A
Trifluoroacetic Acid SCHEMBL2721516 0.75 ALDH1A1 (0.42) PKMHRH4HRH3ALDH1A1KDM1A
Trifluoroacetic Acid SCHEMBL906262 0.75 FAAH (0.41) HRH4HRH3MEN1CYP1A2KMT2A
Trifluoroacetic Acid SCHEMBL3377548 0.75 PLG (0.44) HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326865-B1 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2009-05-06 EP disclosed
US-20050176718-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors ANTHONY NEVILLE J (US) 2005-08-11 US disclosed
US-6921759-B2 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK & CO., INC. (US) 2005-07-26 US disclosed
EP-1326865-A2 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2003-07-16 EP disclosed
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK SHARP & DOHME CORP. 2003-03-20 US disclosed
WO-2002030930-A2 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2002-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors POLI, DUT, NAAA PKM 3331/4885FUCA1 3573/4885HRH4 2742/4885
US-20050176718-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors POLI, DUT, NAAA PKM 3331/4885FUCA1 3573/4885HRH4 2742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.